![]() |
Discontinuation of aromatase inhibitors associated with higher copayments
Discontinuation and nonadherence were higher among breast cancer patients taking brand name aromatase inhibitors (BAIs) vs generic AIs (GAIs), according to a new study published in the JNCI: Journal...
More... |
| All times are GMT -7. The time now is 04:01 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021